Oragenics Inc financial data

Symbol
OGEN on NYSE
Location
1990 Main Street, Suite 750, Sarasota, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 514 % -57.9%
Debt-to-equity 1.35K %
Return On Equity -4.71K % -721%
Return On Assets -325 % +20.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.13M shares -26%
Common Stock, Shares, Outstanding 823K shares -85.3%
Entity Public Float 4.74M USD -29.3%
Common Stock, Value, Issued 823 USD -85.3%
Weighted Average Number of Shares Outstanding, Basic 732K shares +385%
Weighted Average Number of Shares Outstanding, Diluted 732K shares +385%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 37.7K USD -71.4%
Research and Development Expense 3.34M USD -75.1%
General and Administrative Expense 6.2M USD -1.36%
Operating Income (Loss) -9.53M USD +51.5%
Nonoperating Income (Expense) -768K USD -646%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.3M USD +49%
Net Income (Loss) Attributable to Parent -10.3M USD +47.2%
Earnings Per Share, Basic 11 USD/shares +79.7%
Earnings Per Share, Diluted 11 USD/shares +79.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.97M USD +46.4%
Assets, Current 2.14M USD +32.2%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 9.81K USD -97.2%
Assets 2.14M USD -21%
Accrued Liabilities, Current 203K USD -8.94%
Liabilities, Current 1.8M USD +12.6%
Operating Lease, Liability, Noncurrent 65.8K USD -69.7%
Liabilities 4.27M USD +208%
Retained Earnings (Accumulated Deficit) -221M USD -4.88%
Stockholders' Equity Attributable to Parent -2.13M USD -260%
Liabilities and Equity 2.14M USD -21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.11M USD +31.1%
Net Cash Provided by (Used in) Financing Activities 4.67M USD +182%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 823K shares -85.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.56M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.27K USD -11.5%
Deferred Tax Assets, Valuation Allowance 48.4M USD +3%
Deferred Tax Assets, Gross 48.4M USD +3%
Operating Lease, Liability 9.81K USD -97.3%
Lessee, Operating Lease, Liability, to be Paid 9.89K USD -97.4%
Property, Plant and Equipment, Gross 1.48M USD
Operating Lease, Liability, Current 9.81K USD -95.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.89K USD -95.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 381 USD -98.4%
Deferred Tax Assets, Operating Loss Carryforwards 41.1M USD +3.16%
Preferred Stock, Shares Issued 7.49M shares -55.9%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 4.04M USD -3.06%
Operating Lease, Payments 59.3K USD +1.26%
Additional Paid in Capital 219M USD +4.01%
Preferred Stock, Shares Outstanding 7.49M shares -55.9%
Share-based Payment Arrangement, Expense 516K USD -6.19%
Interest Expense 34.3K USD +126%